18th Annual Controversies in Modern Eye Care
May 4, 2024
May 4, 2024
This retrospective analysis of the PRODIGE-35 trial showed that LV5FU2 maintenance after 8 cycles of FOLFIRINOX is feasible in patients treated first line
Samilia Obeng-Gyasi, MD, MPH, expands on the impact of social determinants of health on breast cancer care.
Repotrectinib has been approved by China’s National Medical Products Administration for the treatment of patients with ROS1-positive NSCLC.
This review assesses current evidence and emerging treatment strategies for improved survival among patients with metastatic hormone-sensitive prostate cancer and offers recommendations for clinical practice…
Following the consensus that the risk-benefit assessments for the proposed indications for cilta-cel and ide-cel were favorable during the March 15, 2024, FDA ODAC meeting,…
Over the last ten years, Clinical Trials Day has celebrated achievements from the clinical research community and has shed light on the importance…
The European Society for Medical Oncology (ESMO) Breast Cancer Conference will be held in Berlin, Germany on the 15-17 May. This annual meeting will deliver…
The International Journal of Cancer is a cancer journal from the Union for International Cancer Control covering experimental and clinical cancer research.
In case you missed it, below is your guide to the important regulatory approvals made by the FDA in April 2024.